NEOPHARM, Inc. (Nasdaq: NEOL), today announced fourth-quarter 2006 financial results and updated the status of its drug product candidates. Additionally, the Company has decided to defer the previously scheduled March 14th conference call until early April, after a scheduled late March 2006 meeting with the FDA.
